Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 237

Results For "CRO"

4407 News Found

GMM Pfaudler Q4 FY23 Consolidated PAT jumps to Rs. 38.47 Cr
News | May 26, 2023

GMM Pfaudler Q4 FY23 Consolidated PAT jumps to Rs. 38.47 Cr

The company has reported total income of Rs. 880.59 crores during the period ended March 31, 2023


Lincoln Pharmaceuticals posts FY23 PAT at Rs. 72.90 Cr
News | May 26, 2023

Lincoln Pharmaceuticals posts FY23 PAT at Rs. 72.90 Cr

For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year


Ministry of Minority Affairs supports development of unani medicine system
Policy | May 26, 2023

Ministry of Minority Affairs supports development of unani medicine system

Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru


Lupin Diagnostics Launches Satellite Laboratory in Vijayawada
News | May 26, 2023

Lupin Diagnostics Launches Satellite Laboratory in Vijayawada

Continues to Expand its Presence in South India


Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr
News | May 25, 2023

Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr

The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023


JB Pharma records revenue growth of 22% to Rs. 762 Cr
News | May 25, 2023

JB Pharma records revenue growth of 22% to Rs. 762 Cr

Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23


Mandaviya addresses 76th World Health Assembly
News | May 25, 2023

Mandaviya addresses 76th World Health Assembly

The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world


Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs
Biotech | May 25, 2023

Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs

The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets


Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
News | May 24, 2023

Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr

The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023


Tata 1mg-backed 5C Network launches diagnostics-on-demand platform Prodigi PASS
Healthcare | May 24, 2023

Tata 1mg-backed 5C Network launches diagnostics-on-demand platform Prodigi PASS

5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience